Multicenter, randomized, open-label study of the safety and efficacy of histamine dihydrochloride and interferon alpha-2B for the treatment of chronic hepatitis C: 48-week results
2001 ◽
Vol 34
(0)
◽
pp. 165-166
◽
2002 ◽
Vol 9
(5)
◽
pp. 346-353
◽
2009 ◽
Vol 17
(6)
◽
pp. 410-418
◽
2010 ◽
Vol 8
(1)
◽
pp. 66-71.e1
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 39
(9)
◽
pp. 873-878
◽
Keyword(s):